Masayasu Esaki

1.4k total citations
30 papers, 1.1k citations indexed

About

Masayasu Esaki is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Masayasu Esaki has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 18 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Masayasu Esaki's work include Cardiac Fibrosis and Remodeling (13 papers), Signaling Pathways in Disease (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Masayasu Esaki is often cited by papers focused on Cardiac Fibrosis and Remodeling (13 papers), Signaling Pathways in Disease (7 papers) and Tissue Engineering and Regenerative Medicine (6 papers). Masayasu Esaki collaborates with scholars based in Japan, China and Norway. Masayasu Esaki's co-authors include Hisayoshi Fujiwara, Takako Fujiwara, Rumi Maruyama, Genzou Takemura, Shinya Minatoguchi, Hideshi Okada, Shusaku Miyata, Tomoyuki Takahashi, Hiromitsu Kanamori and Ken-ichiro Kosai and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Masayasu Esaki

29 papers receiving 1.1k citations

Peers

Masayasu Esaki
Longhu Li Japan
Masaharu Okada Japan
Benoit Tricot United States
Gilbert L. Kukielka United States
Raisa Serpi Finland
Sang-Ging Ong United States
Melissa Swinnen Belgium
K. Graf Germany
Kazuko Goto Japan
Wenjun Zhang United States
Longhu Li Japan
Masayasu Esaki
Citations per year, relative to Masayasu Esaki Masayasu Esaki (= 1×) peers Longhu Li

Countries citing papers authored by Masayasu Esaki

Since Specialization
Citations

This map shows the geographic impact of Masayasu Esaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayasu Esaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayasu Esaki more than expected).

Fields of papers citing papers by Masayasu Esaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayasu Esaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayasu Esaki. The network helps show where Masayasu Esaki may publish in the future.

Co-authorship network of co-authors of Masayasu Esaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masayasu Esaki. A scholar is included among the top collaborators of Masayasu Esaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayasu Esaki. Masayasu Esaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ueno, Katsumi, et al.. (2023). Serial quantitative angiographic study of target lumen enlargement after drug‐coated balloon angioplasty for native coronary artery disease. Catheterization and Cardiovascular Interventions. 101(4). 713–721. 10 indexed citations
3.
Ueno, Katsumi, et al.. (2020). Efficacy of Low-Pressure Inflation of Oversized Drug-Coated Balloon for Coronary Artery Disease. Journal of Interventional Cardiology. 2020. 1–10. 3 indexed citations
4.
Kawamura, Itta, Genzou Takemura, Akiko Tsujimoto, et al.. (2011). Treatment of Leg Ischemia With Biodegradable Gelatin Hydrogel Microspheres Incorporating Granulocyte Colony-stimulating Factor. Journal of Cardiovascular Pharmacology. 57(4). 416–423. 12 indexed citations
5.
Li, Longhu, Hideshi Okada, Genzou Takemura, et al.. (2009). Sustained Release of Erythropoietin Using Biodegradable Gelatin Hydrogel Microspheres Persistently Improves Lower Leg Ischemia. Journal of the American College of Cardiology. 53(25). 2378–2388. 27 indexed citations
6.
Miyata, Shusaku, Genzou Takemura, Ken-ichiro Kosai, et al.. (2009). Anti-Fas Gene Therapy Prevents Doxorubicin-Induced Acute Cardiotoxicity through Mechanisms Independent of Apoptosis. American Journal Of Pathology. 176(2). 687–698. 41 indexed citations
7.
Okada, Hideshi, Genzou Takemura, Ken-ichiro Kosai, et al.. (2009). Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure. American Journal of Physiology-Heart and Circulatory Physiology. 296(3). H616–H626. 12 indexed citations
8.
Okada, Hideshi, Genzou Takemura, Yiwen Li, et al.. (2008). Effect of a long‐term treatment with a low‐dose granulocyte colony‐stimulating factor on post‐infarction process in the heart. Journal of Cellular and Molecular Medicine. 12(4). 1272–1283. 21 indexed citations
9.
Takemura, Genzou, Takamasa Ohno, Tomoyuki Takahashi, et al.. (2008). APPLICATION OF AN ADENOVIRAL VECTOR ENCODING SOLUBLE TRANSFORMING GROWTH FACTOR‐β TYPE II RECEPTOR TO THE TREATMENT OF DIABETIC NEPHROPATHY IN MICE. Clinical and Experimental Pharmacology and Physiology. 35(11). 1288–1293. 5 indexed citations
10.
Esaki, Masayasu, Hisayoshi Fujiwara, Genzou Takemura, et al.. (2007). PJ-158 Cationized Gelatin Delivery of a Plasmid Encoding Soluble Fas Mitigates Postinfarction Left Ventricular Remodeling(Acute myocardial infarction, basic-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society). Japanese Circulation Journal-english Edition. 71. 511. 3 indexed citations
11.
Kanamori, Hiromitsu, Genzou Takemura, Yiwen Li, et al.. (2007). Inhibition of Fas-associated apoptosis in granulation tissue cells accompanies attenuation of postinfarction left ventricular remodeling by olmesartan. American Journal of Physiology-Heart and Circulatory Physiology. 292(5). H2184–H2194. 26 indexed citations
12.
Li, Yiwen, Genzou Takemura, Hideshi Okada, et al.. (2007). Molecular Signaling Mediated by Angiotensin II Type 1A Receptor Blockade Leading to Attenuation of Renal Dysfunction-Associated Heart Failure. Journal of Cardiac Failure. 13(2). 155–162. 24 indexed citations
13.
Esaki, Masayasu, Genzou Takemura, Ken-ichiro Kosai, et al.. (2007). Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 294(2). H1048–H1057. 20 indexed citations
14.
Li, Longhu, Genzou Takemura, Yiwen Li, et al.. (2007). Granulocyte colony-stimulating factor improves left ventricular function of doxorubicin-induced cardiomyopathy. Laboratory Investigation. 87(5). 440–455. 38 indexed citations
15.
Li, Yiwen, Genzou Takemura, Hideshi Okada, et al.. (2006). ANG II type 1A receptor signaling causes unfavorable scar dynamics in the postinfarct heart. American Journal of Physiology-Heart and Circulatory Physiology. 292(2). H946–H953. 12 indexed citations
16.
Miyata, Shusaku, Genzou Takemura, Yukinori Kawase, et al.. (2006). Autophagic Cardiomyocyte Death in Cardiomyopathic Hamsters and Its Prevention by Granulocyte Colony-Stimulating Factor. American Journal Of Pathology. 168(2). 386–397. 95 indexed citations
17.
Koda, Masahiko, Genzou Takemura, Hideshi Okada, et al.. (2006). Nuclear Hypertrophy Reflects Increased Biosynthetic Activities in Myocytes of Human Hypertrophic Hearts. Circulation Journal. 70(6). 710–718. 33 indexed citations
18.
Takemura, Genzou, Ken-ichiro Kosai, Ichijiro Murata, et al.. (2005). Hepatocyte Growth Factor Gene Therapy Slows Down the Progression of Diabetic Nephropathy in <i>db/db</i> Mice. Nephron Physiology. 102(3-4). p92–p102. 24 indexed citations
19.
Li, Yiwen, Genzou Takemura, Hideshi Okada, et al.. (2005). Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure. Laboratory Investigation. 86(1). 32–44. 47 indexed citations
20.
Ushikoshi, Hiroaki, Tomoyuki Takahashi, Xuehai Chen, et al.. (2005). Local overexpression of HB-EGF exacerbates remodeling following myocardial infarction by activating noncardiomyocytes. Laboratory Investigation. 85(7). 862–873. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Longhu Li Breakdown of academic impact, for papers by Masaharu Okada Breakdown of academic impact, for papers by Benoit Tricot Breakdown of academic impact, for papers by Gilbert L. Kukielka Breakdown of academic impact, for papers by Raisa Serpi Breakdown of academic impact, for papers by Sang-Ging Ong Breakdown of academic impact, for papers by Melissa Swinnen Breakdown of academic impact, for papers by K. Graf Breakdown of academic impact, for papers by Kazuko Goto Breakdown of academic impact, for papers by Wenjun Zhang
Rankless by CCL
2026